Literature DB >> 16779234

Rare visible disorders/ diseases as individually identifiable health information.

Tewodros Eguale1, Gillian Bartlett, Robyn Tamblyn.   

Abstract

Individually identifiable health information needs to be masked or deleted in the secondary use of data for research. We defined and identified rare visible disorders as part of de-identification of individually identifiable health information. The prevalence of these disorders was evaluated using an administrative database and conformed to our definition. Due emphasis should be given to rare visible disorders in the de-identification process of health information.

Mesh:

Year:  2005        PMID: 16779234      PMCID: PMC1560775     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  5 in total

1.  The disclosure of diagnosis codes can breach research participants' privacy.

Authors:  Grigorios Loukides; Joshua C Denny; Bradley Malin
Journal:  J Am Med Inform Assoc       Date:  2010 May-Jun       Impact factor: 4.497

2.  Evaluating the Risk of Re-identification of Patients from Hospital Prescription Records.

Authors:  Khaled El Emam; Fida K Dankar; Régis Vaillancourt; Tyson Roffey; Mary Lysyk
Journal:  Can J Hosp Pharm       Date:  2009-07

3.  Genetic data sharing and privacy.

Authors:  Marco D Sorani; John K Yue; Sourabh Sharma; Geoffrey T Manley; Adam R Ferguson
Journal:  Neuroinformatics       Date:  2015-01

4.  De-identification methods for open health data: the case of the Heritage Health Prize claims dataset.

Authors:  Khaled El Emam; Luk Arbuckle; Gunes Koru; Benjamin Eze; Lisa Gaudette; Emilio Neri; Sean Rose; Jeremy Howard; Jonathan Gluck
Journal:  J Med Internet Res       Date:  2012-02-27       Impact factor: 5.428

5.  Anonymising and sharing individual patient data.

Authors:  Khaled El Emam; Sam Rodgers; Bradley Malin
Journal:  BMJ       Date:  2015-03-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.